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Background: Traumatic spinal cord injury (SCI) leads to serious neurological and functional deficits through a chain
of pathophysiological events. At the molecular level, progressive damage is initially revealed by collapse of plasma
membrane organization and integrity produced by breaches. Consequently, the loss of its role as a semi-permeable
barrier that generally mediates the regulation and transport of ions and molecules eventually results in cell death.
In previous studies, we have demonstrated the functional recovery of compromised plasma membranes can be
induced by the application of the hydrophilic polymer polyethylene glycol (PEG) after both spinal and brain trauma
in adult rats and guinea pigs. Additionally, efforts have been directed towards a nanoparticle-based PEG application.
The in vivo and ex vivo applications of PEG-decorated silica nanoparticles following CNS injury were able to
effectively and efficiently enhance resealing of damaged cell membranes.
Results: The possibility for selectivity of tetramethyl rhodamine-dextran (TMR) dye-doped, PEG-functionalized silica
nanoparticles (TMR-PSiNPs) to damaged spinal cord was evaluated using an ex vivo model of guinea pig SCI.
Crushed and nearby undamaged spinal cord tissues exhibited an obvious difference in both the imbibement and
accumulation of the TMR-PSiNPs, revealing selective labeling of compression-injured tissues.
Conclusions: These data show that appropriately functionalized nanoparticles can be an efficient means to both
1.) carry drugs, and 2.) apply membrane repair agents where they are needed in focally damaged nervous tissue.Background
Traumatic CNS injury causes sometimes fatal and often se-
vere neurological and functional deficits. Breaches formed
as a result of mechanical damage to the cell membrane
readily triggers a series of adverse events compromising the
plasma membrane’s essential role, progressive disruption of
nearby neuronal tissues, to eventual disruption-induced cell
and tissue necrosis [1-5]. As promising strategies for cir-
cumventing or controlling such membrane disruption, in-
novative molecular - or cellular-based - therapeutic
approaches are now emerging that shows the potential to-
wards clarifying clinical applications [6-8]. Among them,
considerable effort has been directed toward the discovery* Correspondence: cpr@purdue.edu
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reproduction in any medium, provided the orand the administration of synthetic polymers, particularly
polyethylene glycol (PEG) or poloxamer 188 (P188), with a
hope to promote the enhancement of functional recovery
and regeneration [9-17]. Such water-soluble synthetic
polymers are capable of effectively restoring the bar-
rier function of damaged membrane and experimental
rescue of tissues and cells in a wide variety of model
systems. We list a few of both seminal and contem-
porary examples of these wide ranging investigations:
a) rescue of lethally shocked human fibroblasts in vitro
using P 188 [17]; recovery from testicular reperfusion in-
jury using the surfactant T-1100 [18]; functional and
physiological recovery subsequent to IV injection of the
tri-block polymer P188 in guinea pig models of SCI [19];
Restitution of permeabalized skeletal muscle [16]; inter-
ruption in the decline in force-induced deficits in contrac-
tion in a dystrophic mouse model using P 188 [20];
functional recovery and organelle reassembly in an SCI
model using co-polymer – based micro particles [21].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Schematic illustration of the compression injury to the
ex vivo spinal cord tissue. The bottom left shows the compression
injury and adjacent uninjured sites from with 1 cm, 2 cm, and 3 cm
gap (site #1, #2, #3). The upper right shows the front and side view
of modified forceps with a détente 0.8 mm in width when closed by
pressure against the spacer. The isolated spinal cord was placed
between the tips of the forceps to induce the compression injury by
squeezing for 15 sec against the spacer. The graphic is somewhat
exaggerated for the purposes of illustration.
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cation (Topical, Intravenous, Intraperitoneal, and Subcuta-
neous) all significantly benefit physiological, anatomical,
and functional outcome measures in adult guinea pig
models of SCI [5,22], peripheral nerve injury [23],
traumatic brain injury [13,14,24], and in acute veterin-
ary clinical cases of SCI in canines [15]. Others have
experimented with the addition of Magnesium salts to
the PEG solution in SCI (the magnesium having no effect
on outcomes) [25] and found benefit in different types of
adult rat SCI behavioral models [26,27].
In spite of these clear benefits, there are substantial
obstacles for the development of further human clinical
trials. Under certain dosage regimens, the molecular
weight (MW) and aqueous concentration of PEG can be
toxic [28-31]. Indeed, there is a concern for the safety
issue of using low MW PEG, given that toxic complexes
might be generated during the dissociation process of
ethylene glycol into dimers and monomers [32,33]. Add-
itionally, when given by intravenous routes, increased
viscosity of PEG as a consequence of high concentration
might cause problem in systemic circulation. From a
practical standpoint, such limitations would not allow
for sufficient flexibility in preparation and application of
PEG, and might restrict the appropriate use of systemic/
intravenous polymers for maximum efficacy and effi-
ciency. To overcome these problems, we have shifted
our research focus toward the development of
nanoparticle-based membrane applications systems. In
previous studies, PEG-functionalized silica nanoparticles
(PSiNPs) demonstrated a capability to seal damaged cells
and tissues providing neuroprotection subsequent to
spinal cord trauma [34-37]. Specifically, we reported the
beneficial effects of PSiNPs after systemic application,
including physiological recovery of somatosensory
evoked potentials (SSEP) following severe compression
of guinea pig spinal cords. PEG-tethered nanoparticles
offer several advantages over systemic administration of
solutions of these various polymers: i) the large surface
areas of nanoparticles permit significantly greater PEG
delivery at the particular cell/tissue regions of interest.
While the systemic footprint of the polymer would likely
be undetectable [37], ii) PEG-conjugated particles dimin-
ish the current challenges that could arise from the
solution-based administration. Indeed, such nanocarrier
systems not only minimize the amount of free drug in
solution, but also prevent polymer degradation and in-
activation upon administration, [36,38] and iii) the small
size of nanoparticles affords their internalization inside
cells while evading uptake by phagocytic cells [39]. The
latter is particularly important given that rescue of le-
thally poisoned PC 12 cells with Acrolein requires the
internalization of PEG [40], also see Summary Figure 6,
page 136 in [41]. Acrolein is a potent natural aldehydetoxin created as an endpoint to LPO following mechan-
ical trauma to cells [42].
The purpose of this study was to evaluate the selectiv-
ity of TMR-doped, PEG-functionalized silica nanoparti-
cles (TMR-PSiNPs) during the repair of damaged spinal
cord tissue.
Further understanding of the seminal events following
injury-induced CNS cell and tissues damage relative to
secondary injury mechanisms will likely provide appro-
priate and specific treatments for traumatic spinal cord
and brain injury, and possibly other neurodegenerative
disorders [41,42].
Results
The suitable functionalization of the nanoparticles
enables a possible preferential recognition of specific
cells, facilitating binding and affinity-based endocytosis.
Inspired by these important features, silica nanoparticles
were functionalized with recognition elements, or PEG,
on their surfaces, expecting localization toward particu-
larly injured tissue (Figure 2).
As-synthesized, dye-doped silica nanoparticles with a
mean diameter of 150 nm were used for all experiments
detailed in this report. The preparation of dye-doped, PEG
functionalized silica nanoparticles (TMR-PSiNPs) was
initiated via the formation of silica nanoparticles with the
entrapment of hydrophilic organic dye molecules (e.g.,
TMR-dextran) inside the silica pores during hydrolysis
Figure 2 Decorated Peg-coated Nanoparticles. (a) Diagrammatic synthesis of TMR dye-doped, PEG-tagged silica nanoparticle (TMR-PSiNPs).
The particles were separated from microemulsion by vortexing and centrifugating in acetone and ethanol, respectively. (b) ~ (c) TEM images of
bare silica nanoparticles and TMR-doped PEG-coordinated silica nanoparticles (TMR-PSiNPs) with a mean diasmeter of 150 nm. (d) shows the
magnified image of (c) to emphasize the presence of TMR dextran as a black dot in the silica structure. (e) Fluorescence microscopic image of
TMR-PSiNPs.
Chen et al. Journal of Biological Engineering 2012, 6:18 Page 3 of 10
http://www.jbioleng.org/content/6/1/18and sol–gel polymerization of tetraethyl orthosilicate
(TEOS) under the acidic condition (Figure 2(a)). Upon the
preliminary particle preparation, surface modification was
required to activate the surface with PEG layers by con-
verting the end hydroxyl groups to aldehyde substituents
through the reaction with TPA. Consequently, PEG-NH2
was conjugated to the aldehyde moiety through Schiff ’s
base linkage (refer to Figure 2(a)). Figure 2(b) and (c)
showed typical TEM images of bare silica nanoparticles
and TMR-PSiNPs with mean diameters of 150 nm, re-
spectively. PEG-conjugated nanoparticles showed a floc-
culant surface morphology, indicating hydrophilic flexible
chains of PEG were cross-linked on their surfaces. In
addition, the higher magnification image of TMR-PSiNPs
emphasizes the presence of TMR-dextran which appeared
as black spots (Figure 2(d)). Figure 2(e) shows the fluores-
cence images of TMR-PSiNPs with optically manipulated
fluorescent features, where silica network acts primarily as
a supporting barrier to prevent the release of the dye(TMR) from silica pore and to retain its luminophore ac-
tivity. The chemical composition of modified silica surface
was demonstrated by Fourier transform infrared (FT-IR)
spectrometer and X-ray photoelectron spectroscopy
(XPS), indicating the presence of PEG molecules on the
silica surface.
Meanwhile, to evaluate the selective value of the PEG-
conjugated particles, TMR-PSiNPs were tested ex vivo
with fifteen isolated spinal cord tissue samples and we
assessed the degree of particle accumulation by measur-
ing and quantifying the fluorescence intensity within tis-
sue section as a function of distance from the injured
area. Figure 3 displays total fluorescence intensity and
distribution of TMR-PSiNPs, as fluorescent features of
those particles enable visualization through deep-tissue
penetration, particularly within damaged tissues. Inter-
estingly, compression injury induces intense deposition,
or localization, of TMR-PSiNPs in close association with
lesions where intense labeling in both gray and white
Figure 3 Localization of Fluorescently decorated Nanoparticles in Spinal Cord. (a) ~ (d) The evaluation of injury-specific localization of TMR-
PSiNPs to injured and uninjured parenchyma using fluorescence microscopy. Crushed injured vs. uninjured spinal cord tissue are shown by
fluorescence microscopy with 50 μm thick frozen sections. (a) Compression injured cord section while (b) ~ (d) uninjured spinal cord tissues with
a distance of 1 cm, 2 cm, and 3 cm from crush-injured spinal cord site. Obviously, crushed injury caused intense uptake of large amounts of TMR-
PSiNPs represented by significant labeling, especially in gray matter. (e) Quantification of fluorescent intensity in injured and uninjured spinal cord
with background fluorescence normalized by subtraction of background fluorescence (see methods). Results are expressed as a percent of the
uninjured values ± SD (n= 5). **P < 0.001, ***P < 0.005.
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to the highly fluorescent labeled injured tissue, tissues in
close proximity from the injured area (e.g., site #1, #2,
#3) exhibited relatively modest staining, i.e. lower aggre-
gation of particles (Figure 3(b ~ d)). Figure 3(e) showed
the quantification of the concentration of TMR-PSiNPs
in injured and adjacent to injured (uninjured) tissue with
modest distance from the focal injury.Interestingly, the fluorescent intensity of uninjured tis-
sue sections was about 40% lower than that in the
injured tissue. As a control, bare TMR-doped silica
nanoparticles (i.e. not coupled to PEG) were employed
to observe such adsorption and accumulation within
specific injury sites.
In Figure 4, a significant difference in fluorescence in-
tensity between injured and normal tissues was not
Figure 4 Nanoparticle Labeling in Injured and Uninjured Spinal Cord. (a) ~ (d) The evaluation of accumulation of TMR-SiNPs (without PEG
conjugation) to injured and uninjured parenchyma using fluorescence microscopy. (a) Compression injured cord section, and (b) ~ (d) uninjured
spinal cord tissues with a distance of 1 cm, 2 cm, and 3 cm from crush-injured spinal cord segment. It was not surprising that specific interaction
in the uptake of TMR-SiNPs was not observed when PEG was not a component of the complex. (e) Quantification of fluorescent intensity in
injured and uninjured spinal cord with background fluorescence normalized and with the subtraction of background fluorescence (see methods).
Results are expressed as a percent of the uninjured values ± SD (n= 5).
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PEG attached to particles is a key factor in promoting
anatomical sealing of damaged neuron membranes sup-
ported by this affinity.. We also qualitatively studied the
distribution of nanoparticles using SEM. Given the clear
localization to the insult discussed above, an anatomical
difference should be apparent. In support of these data,
there appeared to be obvious differences in the
localization of TMR-PSiNPs along the long axis of the
cord with distance from the lesion. The higher-resolution SEM image revealed the localization of the
particles within the lesioned tissue whereas the presence
of particles was greatly decreased from the injured site
as shown in Figure 5.
Indeed, the accumulation of nanoparticles to cord tis-
sue was most reduced at site #3, located a distance of
3 cm from the compression injury. Finally, the presence
of silica particles within the tissues was also observed
using the XPS spectrum (Figure 6). The high-resolution
Si 2p spectra exhibited an obvious signal through the
Figure 5 PSiNP Accumulations visualized by SEM. The cross sectional SEM images of injured spinal cord (a) and uninjured spinal cords
located at site #1 (b), site #2 (c), and site #3 (d) upon immediate post treatment with TMR-PSiNPs. Some, but not all, of individual and aggregated
nanoparticles have been highlighted in green and yellow. Note the existence of dense particles in Figure 6a.
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through the intact cord tissues.
Discussion
Sealants, Fusogens, and the Damaged Cell Membrane
Since strongly hydrophilic polymers enabled the fusion
of intact cells during the formation of hybridomas – it
was a short jump in logic to hypothesized that parts of
cleaved or diced cells might also be functionally reat-
tached as well. This was first demonstrated by Bittner
[43] who cut dissected giant axon from earthworm into
two pieces and then subsequently functionally reattached
them with PEG. The biophysics permitting the “fuso-
genic” properties of PEG and multi-block polymers
(Poloxamers and Poloxamines) have been investigated
for over three decades in cells and model membranes. As
mentioned above, a complete understanding of the bio-
physics and mechanisms of fusion – let alone membrane
repair – by these agents still alludes us. A discussion of
the biophysics underlying fusion is beyond the scope of
this investigative report – but we direct the interested
reader to reviews of this subject [4,41,42,44-46].
Once again we provide seminal thoughts from the
clear leaders in this scholarship [44,45,47] and contem-
porary understandings spanning decades to note theevolution in thinking about the mechanisms of action of
polymer/surfactant based membrane fusion.
It is agreed that these hydrophilic polymers stabilize
closely apposed, yet separate, cell membrane through
interaction with, and alteration of, the aqueous phase of
membrane amphilic phospholipids, as well as permit or
induce the commingling of the hydrophic phase during
membrane fusion. As Lee and others have taught –
membrane fusion is intimately associated with the
organization of water at opposing membranes.
It is difficult to extrapolate experimental and theoret-
ical understandings from polymer – based cell fusion
studies to cell repair strategies. In the latter, it is likely
that the significant hydrophilia of the repair agent is of
prime importance. To rescue damaged but surviving
cells, secondary dehydration of the “lesion” may be the
most important outcome (refer to summary Figure 2
and 3; page 128 in [41]. In the absence of water within
the breech, the lipid phases spontaneously reassemble
ie., resolving together as an unbroken phase from the
margins. This reestablishes the characteristic form of
the membrane and the polar forces associated with the
aqueous phase of the reconstituting membrane may
reestablish much of the geometry of protein machinery
of the membrane held in place in part by these polar
Figure 6 Evaluating the presence of TMR-PSiNPs in the injured vs. uninjured spinal cords by XPS. High-resolution XPS surface
deconvolution analysis of Si 2p was used to verify the existence of silica nanoparticles on (a) crush-injured cord tissue and (b) uninjured cord
located at site #2. Note that the compression injury increased the level of silica, identifying a precise targeting toward injured regions.
Chen et al. Journal of Biological Engineering 2012, 6:18 Page 7 of 10
http://www.jbioleng.org/content/6/1/18forces. These mechanisms, actual and theoretical, probe
the ability of hydrophilic polymers to functionally re-
constitute a variety of cell types and tissues and require
more investigation.
Evaluation of the localization of TMR-PSiNPs in injured
and uninjured spinal cord tissues
Recently, we have reported the ability of PEG-coated sil-
ica nanoparticles (PSiNPs) in the restoration of integrity
of the structurally and physiologically damaged spinal
cord tissues [34,37]. However, “targeting” (see below) the
molecule to the specific cells/tissues becomes crucial to
prevent adverse effects, and to enhance the density of
PEG at only sites of damage. This then reduces the ac-
tual amount of PEG in systemic circulation at times after
administration to vanishingly low.
In this study, crushed cords were incubated in the
TMR-PSiNP solution for 15 min followed by the
immersion in oxygenated Krebs’ for an additional
30 min. This process might readily account for the re-
duction in non-specific binding affinity between cord tis-
sues and TMR-PSiNPs, thus indicating low background
staining. Overall, our experimental results indicated that
total accumulation as an indicative for the presence of
TMR-PSiNPs subtly lowered in proportion to the dis-
tance from the injured area.
This study model – using the same cord as its own
control has been verified and standardized. Briefly, the
most sensitive indicator of membrane /tissue damage is
an ionic current that flows into the compromised region[48-50]. The magnitude of the current is indicative
somewhat of the size of the injury. This is because all
cells are inwardly negative and this membrane “battery”
drives net current into an insult (be it a region of low-
ered membrane resistivity or an actual breach). We have
measured such currents non- invasively entering axons
and tracts of mammalian white matter with vibrating
and neutating microprobe systems for the measurement
of extracellular current [50]. In these ex vivo mammalian
spinal cord segments – injury current is largely
restricted to the region of a standardized compression
(see below) and falls off steeply by 50 microns from it;
see pages 5–6 in Zuberi et al. [50]. The comparative seg-
ments of cord are indeed adjacent to the injury zone and
provide undamaged white matter for comparison to the
central injury. This “control region” of this same cord
shows no signs of anatomical or physiological damage.
This model we believe is superior to using separate con-
trol cords.
We believe that the PEG-conjugated particles specific-
ally provide selective binding to the damaged cell’s sur-
faces, and thus allows for subsequent intracellular
accumulation of significant amounts of nanoparticles
with suitably adjusted affinities. In the uninjured seg-
ments, there appeared an obvious difference in the label-
ing of gray and white matter. This is likely due to the
fact that neurons large clusters are only found in gray
matter. Thus, gray matter may be a more useful site of
absorption of particles compared to white matter com-
posed of only nerve axons. This would be an especially
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involves loss of cerebral neurons.
Our data both extends and supports the induction of
spontaneous reassembly of damaged membranes of
nerves and other cells, their anatomical sealing, and the
immediate recovery of nerve conduction through spinal
cord by specific localization of PEG where it is most
useful.New directions
This paper is a part of a new investigation of several re-
placement strategies to the application of native PEG for
the reasons given above. These also include polysacchar-
ides that are also strongly hydrophilic, can act as “sea-
lants”, are biodegradable, and completely nontoxic
[41,51]. Sugars derivatives such as Chitosan may also
directly target membrane defects using a more appro-
priated nomenclature.
We [41] as others have used “targeting” to describe a
synthetic polymer’s mode of action in repairing cell
defects. In reflection this is likely an illegitimate descrip-
tor. It implies a more precise understanding of the
mechanisms of specific recognition phenomenon such
as observed in ligand / receptor coupling or immuno-
logical recognition strategies used in biology and medi-
cine. Thus we have moved away from this term here to
describe instead the affinity of symmetric polymers for
regions of cell and tissue defects that have been empiric-
ally reported in SCI and TBI [14]. On the other hand – it
may be completely accurate to describe Chitosan’s ability
to “recognize” and selectively adhere to cell membrane
defects Here the molecular interactions of complex and
disorganized lipids and reactive sites on chitosan are
understood [41,52,53].Conclusions
In this study, we have observed accumulations of TMR-
PSiNPs in injured spinal cord tissue compared to nearby
“undamaged” tissue. The results revealed a significant
interaction of PEG-conjugated nanoparticles toward a
compression injury, while there did not appear any ap-
parent association to nearby uninjured tissues. An im-
portant fact explaining any aggregation at all in
“uninjured tissues” is to recall the amount of handling
and surgery used to provide the ex vivo samples of spinal
cord for study. Indeed, this preferential targeting study
strongly supports the initial observations with regard to
PEG-mediated spontaneous reorganization, anatomical
sealing, and recovery of conduction through guinea pig
spinal cord white matter. These data also support PEG –
induced dramatic restoration of cerebral cells in
damaged brain and recovery of function after such sig-
nificant injury [24,54,55].Methods
Synthesis and functionalization of TMR-doped,
PEG-functionalized Silica
Nanoparticles (TMR-PSiNPs)
All chemicals were purchased from Sigma-Aldrich unless
otherwise specified. TMR-doped, PEG-modified silica
nanoparticles were synthesized according to the previ-
ously described procedure [37]. In brief, the mixture com-
posed of 1.77 mL of Triton X-100, 1.8 mL of n-hexanol,
7.5 mL of cyclohexane, and 0.5 mL of 1% aqueous tetra-
methyl rhodamine-dextran (TMR-dextran, Invitrogen) so-
lution was prepared to form water-in-oil (W/O) reverse
microemulsion by adjusting solution pH to 2.0. Then, 100
μL of tetraethyl orthosilicate (TEOS) was slowly added to
the mixture with vigorous stirring. The solutions were
stirred for another 1 hr until 60 μL of NH4OH was added
to the solution to terminate polymerization reaction. By
adding acetone, the fluffy white precipitate was collected
by repetitive vortexing and centrifugation. TMR-doped
silica nanoparticles were rinsed with ethanol and acetone
several times, and dried under vacuum at 100°C for
12 hr. Subsequently, silica nanoparticles were linked with
PEG through two consecutive steps: i) the reaction be-
tween silanol groups on silica surfaces and aldehyde
groups from 3-(trimethoxysilyl) propyl aldehyde (TPA)
and ii) subsequent conjugation of PEG-NH2 (M.W. 3000)
via a reactive schiff ’s base linkage. Particle morphology
and size was observed by scanning electron microscope
and transmission electron microscope (JEOL 2000FX).
The presence of PEG attached on the silica surface was
verified using Fourier Transform-Infrared Reflection
Absorption Spectroscopy (FT-IRRAS) (data not shown).
Isolation of adult guinea pig spinal cords and inducement
of injury
All guinea pigs used in this study were handled in ac-
cordance with Purdue Animal Care and Use Committee
(PACUC) guidelines. Fifteen adult female guinea pigs, of
the Hartley strain (300 plus grams) were anesthetized
with an intramuscular injection of ketamine (60 mg/kg)
and xylazine (10 mg/kg). Then they were perfused
through the heart with approximately 500 ml of sterile
lactated ringer (SLR) solution to remove the blood. The
vertebral column was then rapidly removed and a
complete dorsal laminectomy performed along the
length of the vertebral column, exposing the spinal cord.
The spinal cord was carefully removed from vertebrae
and immersed in cold, oxygenated Kreb’s solution
(124 mM NaCl, 2 mM KCl, 1.24 mM KH2PO4, 1.3 mM
MgSO4, 1.2 mM CaCl2, 10 mM glucose, 26 mM
NaHCO3, and 10 mM ascorbic acid).
A standardized compression injury was induced using
a modified forceps possessing a detente by constant
mechanical force for 15 sec (Figure 1). Previously
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(CAP) conduction through whole guinea pig spinal cord
using the Double Sucrose Gap Isolation / Recording
chamber (DSGR) verified the immediate and complete
loss of conduction through such constant displacement
compression injury produced in this way [56,57].
Evaluation of targeting ability of TMR-PSiNPs in the spinal
cord tissues
As nanoparticle targeting to a desired location improves
therapeutic response, TMR-PSiNPs were applied to the
segments of ex vivo spinal cord tissues containing com-
pression injury and three different intact sites to evaluate
the distribution and localization of the particles. The le-
sion was centrally located along the long axis of the
cord, and the three uninjured sites of study were situated
1 cm, 2 cm, and 3 cm from it (Figure 1). The compres-
sion injured spinal cord tissue was incubated in the sus-
pension of TMR-PSiNPs for 15 min followed by the
immersion in modified Krebs’s solution for another
30 min. The spinal cords were immediately fixed in 4%
paraformaldehyde, sectioned with a freezing microtome
with 50 μm thick and evaluated with a fluorescent
microscope using excitation/barrier wavelengths of 545/
590 nm, respectively. Labeling with a TMR dye was
quantified using NIH Image™ software by statistically
measuring fluorescence (minus background) intensity.
As in prior studies the existence of differing levels of
background fluorescence in the samples was normalized
by measurement of fluorescence within standardized
regions of background at a standard distance from the
region of interest – and subtracting this to normalize
this data; [37,51].
For Scanning Electron Microscope (SEM) measure-
ments, tissue sections containing particles were fixed in
2.5% glutaraldehyde, and dehydrated with increasing
concentrations of ethanol by conventional methods.
After drying, the silica nanoparticles were observed after
a JEOL JFC-110 ion sputtering (Tokyo, Japan) and ana-
lyzed in a JEOL JSM-840 SEM. As another complemen-
tary test, the existence of particles within the spinal cord
tissues was evaluated using Kratos Axis ULTRA X-ray
Photoelectron Spectrometer.
Statistical analysis
Unless otherwise specified, unpaired student’s t test (for
comparison of 2 groups) or one-way ANOVA and Post
Hoc Newman Keul’s test (for more than 2 groups) were
used for statistical analyses (InStat™ software). Normality
was tested by Shapiro-Wilk test (STATA). Equal var-
iances were tested by the method of Barlett for n ≥ 5
(InStat™ software), and by less than 2-fold difference in
SD for n < 5. Results are expressed as mean ± SD.
P < 0.05 was considered statistically significant.Competing interests
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